Susquehanna Fundamental Investments, LLC Eagle Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$36.86 - $44.5 $211,908 - $255,830	-5,749 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $312,600 - $395,170	-7,753 Reduced 57.42%	5,749 $240,000
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $22,862 - $28,134	-548 Reduced 3.9%	13,502 $629,000
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $125,868 - $174,352	3,400 Added 31.92%	14,050 $597,000
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $460,506 - $585,963	10,650 New	10,650 $511,000

9.89M

1.01M

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $55.7M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.